insiderdelta

Deciphera Pharmaceuticals, Inc.

DCPHCIK 0001654151 · Every Form 4 filed by insiders at this issuer.

Filings

15

Latest Feb 20, 2024

Unique insiders

11

Showing

15 of 15

Page 1

Top insiders

Most active reporters at Deciphera Pharmaceuticals, Inc.

NameRolesFilings
Kelly Thomas Patrick
Officer
2
Martin Daniel C.
Officer
2
Pitman Jama
Officer
2
Sherman Matthew L
Officer
2
Allen Patricia L
Director
1
Brightstar Associates LLC
10% Owner
1
Dhanak Dashyant
Officer
1
Friedman Franklin Stuart
Director
1
Hoerter Steven L.
OfficerDirector
1
Squarer Ron
Director
1

All filings

15 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Feb 20, 2024
Pitman Jama
SVP, Chief Development Officer
S2,267$15.6176$35,405
Feb 20, 2024
Sherman Matthew L
EVP & Chief Medical Officer
S2,615$15.6177$40,840
Feb 20, 2024
Martin Daniel C.
Chief Commercial Officer
S2,267$15.6176$35,405
Feb 20, 2024
Dhanak Dashyant
EVP & Chief Scientific Officer
A17,275$0.00$0
Feb 20, 2024
Hoerter Steven L.
President and CEO · Director
Holdings only———
Feb 20, 2024
Kelly Thomas Patrick
Chief Financial Officer
S3,010$15.6177$47,009
Feb 9, 2024
Brightstar Associates LLC
10% Owner
X914,001$0.01$9,140
Jan 18, 2024
Squarer Ron
Director
Holdings only———
Jan 18, 2024
Allen Patricia L
Director
Holdings only———
Jan 18, 2024
Martin Daniel C.
Chief Commercial Officer
S1,624$14.4697$23,499
Jan 18, 2024
Kelly Thomas Patrick
Chief Financial Officer
S2,435$14.4698$35,234
Jan 18, 2024
Friedman Franklin Stuart
Director
Holdings only———
Jan 18, 2024
Pitman Jama
SVP, Chief Development Officer
S1,624$14.4698$23,499
Jan 18, 2024
Walsh Dennis Leo
Director
Holdings only———
Jan 18, 2024
Sherman Matthew L
EVP & Chief Medical Officer
S2,435$14.4697$35,234

Showing 1–15 of 15

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.